Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 232561, 8 pages
http://dx.doi.org/10.1155/2014/232561
Clinical Study

5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns

1Department of Neurosurgery, Padua University Hospital, Azienda Ospedaliera di Padova, Via Giustiniani 2, 35128 Padova, Italy
2Department of Oncology, IOV IRCCS Oncology Institute of Padua, Via Gattamelata 64, 35128 Padova, Italy
3Neuroradiology Unit, Padua University Hospital, Via Giustiniani 2, Padua, 35128 Padova, Italy
4Department of Medicine (DIMED), Nuclear Medicine Service, University of Padua, Via Giustiniani 2, 35128 Padova, Italy

Received 11 February 2014; Accepted 10 March 2014; Published 8 April 2014

Academic Editor: Anna Luisa Di Stefano

Copyright © 2014 Alessandro Della Puppa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Sanai and M. S. Berger, “Glioma extent of resection and its impact on patient outcome,” Neurosurgery, vol. 62, no. 4, pp. 753–764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Hardesty and N. Sanai, “The value of glioma extent of resection in the modern neurosurgical era,” Frontiers in Neurology, vol. 3, article 140, 2012. View at Google Scholar
  3. M. J. McGirt, D. Mukherjee, K. L. Chaichana, K. D. Than, J. D. Weingart, and A. Quinones-Hinojosa, “Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme,” Neurosurgery, vol. 65, no. 3, pp. 463–469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Lacroix, D. Abi-Said, D. R. Fourney et al., “A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival,” Journal of Neurosurgery, vol. 95, no. 2, pp. 190–198, 2001. View at Google Scholar · View at Scopus
  5. N. Sanai, M. Polley, M. W. McDermott, A. T. Parsa, and M. S. Berger, “An extent of resection threshold for newly diagnosed glioblastomas: clinical article,” Journal of Neurosurgery, vol. 115, no. 1, pp. 3–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. E. Keles, K. R. Lamborn, S. M. Chang, M. D. Prados, and M. S. Berger, “Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy,” Journal of Neurosurgery, vol. 100, no. 1, pp. 41–46, 2004. View at Google Scholar · View at Scopus
  7. K. L. Chaichana, I. Jusue-Torres, R. Navarro-Ramirez et al., “Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma,” Neuro-Oncology, no. 1, pp. 113–122, 2014. View at Google Scholar
  8. M. A. Idoate, R. Díez Valle, J. Echeveste, and S. Tejada, “Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence,” Neuropathology, vol. 31, no. 6, pp. 575–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Stummer, U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella, and H. Reulen, “Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial,” The Lancet Oncology, vol. 7, no. 5, pp. 392–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Stummer, H. Reulen, T. Meinel et al., “Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias,” Neurosurgery, vol. 62, no. 3, pp. 564–576, 2008. View at Google Scholar · View at Scopus
  11. G. C. Feigl, R. Ritz, M. Moraes et al., “Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring,” Journal of Neurosurgery, vol. 113, no. 2, pp. 352–357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Díez Valle, S. Tejada Solis, M. A. Idoate Gastearena, R. García de Eulate, P. Domínguez Echávarri, and J. Aristu Mendiroz, “Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience,” Journal of Neuro-Oncology, vol. 102, no. 1, pp. 105–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Schucht, J. Beck, J. Abu-Isa et al., “Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-ALA intraoperative fluorescence imaging and brain mapping,” Neurosurgery, vol. 71, no. 5, pp. 927–935, 2012. View at Google Scholar
  14. R. Sawaya, M. Hammoud, D. Schoppa et al., “Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors,” Neurosurgery, vol. 42, no. 5, pp. 1044–1055, 1998. View at Google Scholar · View at Scopus
  15. W. Stummer, A. Novotny, H. Stepp, C. Goetz, K. Bise, and H. J. Reulen, “Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients,” Journal of Neurosurgery, vol. 93, no. 6, pp. 1003–1013, 2000. View at Google Scholar · View at Scopus
  16. A. della Puppa, S. de Pellegrin, E. d'Avella et al., “5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature,” Acta Neurochirurgica, vol. 155, no. 6, pp. 965–972, 2013. View at Google Scholar
  17. N. Butowski, K. R. Lamborn, M. S. Berger, M. D. Prados, and S. M. Chang, “Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme,” Journal of Neuro-Oncology, vol. 85, no. 1, pp. 87–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Vogelbaum, S. Jost, M. K. Aghi et al., “Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) working group,” Neurosurgery, vol. 70, no. 1, pp. 234–243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Rampazzo, A. della Puppa, C. Frasson et al., “Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery,” Journal of Neuro-Oncology, vol. 116, no. 3, pp. 505–513, 2014. View at Google Scholar
  20. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, no. 2, pp. 97–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Senft, M. Forster, A. Bink et al., “Optimizing the extent of resection in eloquently located gliomas by combining intraoperative MRI guidance with intraoperative neurophysiological monitoring,” Journal of Neuro-Oncology, vol. 109, no. 1, pp. 81–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Nabavi, P. M. Black, D. T. Gering et al., “Serial intraoperative magnetic resonance imaging of brain shift,” Neurosurgery, vol. 48, no. 4, pp. 787–797, 2001. View at Google Scholar · View at Scopus
  23. P. Schucht, S. Knittel, J. Slotboom et al., “5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma,” Acta Neurochirurgica, vol. 156, no. 2, pp. 305–312, 2014. View at Google Scholar
  24. L. Persano, E. Rampazzo, A. della Puppa, F. Pistollato, and G. Basso, “The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications,” TheScientificWorldJournal, vol. 11, pp. 1829–1841, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Widhalm, S. Wolfsberger, G. Minchev et al., “5-aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement,” Cancer, vol. 116, no. 6, pp. 1545–1552, 2010. View at Publisher · View at Google Scholar · View at Scopus